Gene · 9476
Papers2,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,888
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRANS: a prediction model for EGFR mutation status in NSCLC based on radiomics and clinical features. | Respir Res | 2025 | 40474176 | PubTator, text mining | PubMed |
| Usefulness of CD56, BRAF and CD15 in the differential diagnosis of thyroid lesions with nuclear features of papillary carcinoma. | Pathol Res Pract | 2025 | 40424929 | PubTator, text mining | PubMed |
| Cytopathology of Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report. | Cureus | 2025 | 40406754 | PubTator, text mining | PubMed |
| Concurrent SMARCA4-deficient and poorly differentiated adenocarcinomas in separate lung lobes: a case report and literature review. | World J Surg Oncol | 2025 | 40405273 | PubTator, text mining | PubMed |
| Primary pleural small cell carcinoma with massive pleural effusion: A rare case report. | Int J Surg Case Rep | 2025 | 40403473 | PubTator, text mining | PubMed |
| SMARCA4 deficiency: implications for non-small cell lung cancer and management strategies, with relevance to and distinctions from thoracic undifferentiated tumor. | Transl Lung Cancer Res | 2025 | 40386720 | PubTator, text mining | PubMed |
| Vitiligo-like rash in a patient with lung cancer caused by sintilimab: A case report. | World J Clin Cases | 2025 | 40385299 | PubTator, text mining | PubMed |
| Napsin-A Expression in Mesonephric and Mesonephric-like Adenocarcinomas: Implications for Distinction From Clear Cell Carcinoma. | Int J Gynecol Pathol | 2025 | 40377328 | PubTator, text mining | PubMed |
| EGFR-mutant lung adenocarcinoma transformed into small cell Lung cancer: A case report and literatures review. | Respir Med Case Rep | 2025 | 40371436 | PubTator, text mining | PubMed |
| Acquired ROS1 fusion and iruplinalkib response in advanced NSCLC after multiple lines of systematic therapy: a case report. | Front Oncol | 2025 | 40371229 | PubTator, text mining | PubMed |
| Pulmonary pleomorphic carcinoma associated with cystic airspace and recurrent spontaneous pneumothorax: A case report. | Oncol Lett | 2025 | 40351604 | PubTator, text mining | PubMed |
| "Early" Clear Cell Proliferations (Clear Cell Carcinoma in Situ) in Ovarian Endometriotic Cysts: Report of a Case Series With Recommendations for Terminology. | Am J Surg Pathol | 2025 | 40326407 | PubTator, text mining | PubMed |
| Napsin A as a key prognostic biomarker in spinal metastases of lung cancer: implications for survival and neurological function. | Neurosurg Focus | 2025 | 40311196 | PubTator, text mining | PubMed |
| A critical appraisal of the clinico-radiological, histopathological and immunohistochemical profile of CT-guided and bronchoscopy-guided biopsies in lung lesions. | Lung India | 2025 | 40296393 | PubTator, text mining | PubMed |
| Bilateral primary ovarian clear cell carcinoma in a multiparous perimenopausal woman. | Rev Esp Patol | 2025 | 40252630 | PubTator, text mining | PubMed |
| Multiple pulmonary mucinous cystadenoma with Ovarian-like stroma: a case report. | Diagn Pathol | 2025 | 40241216 | PubTator, text mining | PubMed |
| Revealing NAPSA's role in ccRCC: Insights from single-cell RNA sequencing. | Gene | 2025 | 40194687 | PubTator, text mining | PubMed |
| Primary Peritoneal Clear Cell Carcinoma Presenting with Nonspecific Gastrointestinal Symptoms in a 39-Year-Old Woman: A Case Report. | Case Rep Gastroenterol | 2025 | 40135043 | PubTator, text mining | PubMed |
| Overlapping nuclear import and export paths unveiled by two-colour MINFLUX. | Nature | 2025 | 40108461 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Reveals PD-L1-Mediated Immune Escape Signaling in Lung Adenocarcinoma. | J Cancer | 2025 | 39991571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9476/papers?page=9